Purinostat, CAS [[1929583-17-4]]

Produktübersicht

• Artikelname: Purinostat, CAS [[1929583-17-4]]
• Artikelnummer: MCE-HY-150109A
• Hersteller Artikelnummer: HY-150109A
• Alternativnummer: MCE-HY-150109A-10MG,MCE-HY-150109A-100MG,MCE-HY-150109A-5MG,MCE-HY-150109A-50MG,MCE-HY-150109A-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

Purinostat is a selective inhibitor of HDAC I/IIb with anti-leukemic activity. Purinostat mesylate (HY-150109), the mesylate salt of Purinostat, inhibits the survival of Ph+ leukemic cells and CD34+ leukemic cells derived from CML patients. Purinostat mesylate targets HDAC I/IIb to inhibit several important factors for leukemic stem cell (LSC) survival, including c-Myc, beta-Catenin, E2f, Ezh2, Alox5, and mTOR. Purinostat mesylate increases glutamate metabolism in LSC by increasing GLS1[1].

Produkteigenschaften

• Molekulargewicht: 490.52
• Reinheit: 98.04
• CAS Nummer: [1929583-17-4]
• Formel: C23H26N10O3
• Target-Kategorie: HDAC

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound1